| Category,Data Item Code,Data Item Name,SC,PHC/UPHC,CHC,SDH,DH,MC,AYUSH,Other Format,PVT,BHQ,DHQ | |
| M1 [Ante Natal Care (ANC)],1.1,Total number of NEW Pregnant Women registered for ANC ,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,, | |
| ,1.1.a,Out of total number of NEW Pregnant Women registered with age less than <15 years ,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,, | |
| ,1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years ,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,, | |
| ,1.1.c,Out of total number of NEW Pregnant Women registered with age more than >19 to 49 years ,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,, | |
| ,1.1.d,Out of total number of NEW Pregnant Women registered with age more than >49 years ,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,, | |
| ,1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks) ",1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,, | |
| ,1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,1.1.2,1.1.2,1.1.2,1.1.2.,1.1.2.,1.1.2,1.1.2,1.1.2,1.1.2.,, | |
| ,1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1) ,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,, | |
| ,1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2) ,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,, | |
| ,1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster) ,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,, | |
| ,1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,, | |
| ,1.2.5,Number of PW provided full course 360 Calcium tablets ,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,, | |
| ,1.2.6,Number of PW given one Albendazole tablet after 1st trimester ,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,,1.2.6.,, | |
| ,1.2.7,Number of PW received 4 or more ANC check ups ,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.6.,1.2.7.,, | |
| ,1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour ,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,,1.2.8.,, | |
| ,1.3.1,New cases of PW with hypertension detected ,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,, | |
| ,1.3.2,Number of PW with hypertension managed at institution ,,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,, | |
| ,1.3.3.,Number of New Pre-Eclampsia/Eclampsia cases identified ,1.3.2.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,,1.3.3.,, | |
| ,1.3.4,Number of Pre-Eclampsia/Eclampsia cases managed during ANC ,,1.3.4.,1.3.4.,1.3.4.,1.3.4.,1.3.4.,1.3.4.,,1.3.4.,, | |
| ,1.3.5,Number of Eclampsia cases managed during delivery ,,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.3.,1.3.5.,, | |
| M1 [Ante Natal Care (ANC)],1.4.1.,Number of PW tested for Haemoglobin (Hb) 4 or more than 4 times for respective ANCs ,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,, | |
| ,1.4.2.,Number of PW tested for Haemoglobin (Hb) ,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,, | |
| ,1.4.3.,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases) ,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,, | |
| ,1.4.4.,Number of PW having Hb level<=7 g/dl (Out of total tested cases) ,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,, | |
| ,1.4.5.,Number of PW treated for severe anaemia (Hb<=7g/dl) (including referred-in cases) ,,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,, | |
| ,1.5.1.,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test) ,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,, | |
| ,1.5.2.,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted ,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,, | |
| ,1.5.3.,Number of GDM positive PW managed with Insulin/Metformin out of total tested positive for GDM ,,1.5.3.,1.5.3.,1.5.3.,1.5.3.,1.5.3.,1.5.3.,,1.5.3.,, | |
| ,1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis ,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,,1.6.1.a,, | |
| ,1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test ,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,,1.6.1.b,, | |
| ,1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM) ,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,,1.6.1.c,, | |
| ,1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women ,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,,1.6.1.d,, | |
| ,1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,,1.6.1.e,, | |
| ,1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,,1.6.1.f,, | |
| ,1.7.1.,Number of Pregnant Women tested positive for Thyroid disorder ,,1.7.1.,1.7.1.,1.7.1.,1.7.1.,1.7.1.,1.7.1.,,1.7.1.,, | |
| ,1.7.2.,Number of Pregnant Women treated for thyroid disorder ,,1.7.2.,1.7.2.,1.7.2.,1.7.2.,1.7.2.,1.7.2.,,1.7.2.,, | |
| ,1.8.1.,Number of Pregnant Women screened for TB ,1.7.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,,1.8.1.,, | |
| ,1.8.2.,Number of Pregnant Women identified with Presumptive TB symptoms ,1.7.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,,1.8.2.,, | |
| M1 [Ante Natal Care (ANC)],1.8.3.,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,1.7.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,,1.8.3.,, | |
| ,1.9.1.,Total High Risk Pregnancy (HRP) Intrapartum including following: ,1.8.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,,1.9.1.,, | |
| ,1.9.1.a.,Number of Pregnant Women only with Post-Partum Haemorrhage(Immediately after delivery) in the facility ,1.8.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,,1.9.1.a.,, | |
| ,1.9.1.b.,Number of Pregnant Women only with Sepsis in the facility ,1.8.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,,1.9.1.b.,, | |
| ,1.9.1.c.,Number of Pregnant Women identified only with Eclampsia in the facility ,1.8.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,,1.9.1.c.,, | |
| ,1.9.1.d.,Number of Pregnant Women identified only with obstructed labour in the facility ,1.8.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,,1.9.1.d.,, | |
| ,1.9.1.e.,Number of Pregnant Women identified with more than 1 complication listed above ,1.8.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,,1.9.1.e.,, | |
| ,1.9.2.,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported) ,1.8.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,,1.9.2.,, | |
| ,1.9.3.,Total no. of highrisk ANC cases referred to Higher/ any other facility (Referred out) ,1.8.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,,1.9.3.,, | |
| ,1.9.3.a.,Total no. of Intrapartum/PNC High Risk Pregnancy cases referred to Higher/ any other facility (Referred out) ,1.8.3.a,1.9.3.a,1.9.3.a.,1.9.3.a.,1.9.3.a.,1.9.3.a,1.9.3.a,,1.9.3.a.,, | |
| ,1.9.4.,Total no. of highrisk ANC cases referred in to the facility (Referred in) ,,1.9.4,1.9.4.,1.9.4.,1.9.4.,1.9.4.,1.9.4,,1.9.4.,, | |
| ,1.9.4.a.,Total no. of Intrapartum/PNC High Risk Pregnancy cases attended or referred into the facility (Referred in) ,,1.9.4.a,1.9.4.a,1.9.4.a.,1.9.4.a.,1.9.4.a,1.9.4.a,,1.9.4.a.,, | |
| M2 [Deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2.1.1.a,2.1.1.a,2.1.1.a,2.1.1.a,2.1.1.a,,2.1.1.a,,2.1.1.a,, | |
| ,2.1.1.b,Number of Home Deliveries attended by Non SBA ,2.1.1.b,2.1.1.b,2.1.1.b,2.1.1.b,2.1.1.b,,2.1.1.b,,2.1.1.b,, | |
| ,2.1.2.,Number of PW given Tablet Misoprostol during home delivery ,2.1.2.,2.1.2.,2.1.2.,2.1.2.,2.1.2.,,2.1.2.,,2.1.2.,, | |
| ,2.2.,Number of Institutional Deliveries conducted (Including C-Sections) ,2.2.,2.2.,2.2.,2.2.,2.2.,2.1.,2.2.,2.1.,2.2.,, | |
| ,2.2.1.,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery ",2.2.1.,2.2.1.,2.2.1.,2.2.1.,2.2.1.,2.1.1.,2.2.1.,,2.2.1.,, | |
| M2 [Deliveries],2.2.2.,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM) ",2.2.2.,2.2.2,2.2.2,2.2.2,2.2.2.,2.1.2.,2.2.2,,2.2.2,, | |
| ,2.2.3.,"Out of total Institutional deliveries, number of institutional deliveries conducted at Midwifery Led Care Unit (MLCU) ",,,2.2.3.,2.2.3.,2.2.3.,2.1.3.,,,2.2.3.,, | |
| ,2.3.1.,"Out of total number of delivery, PW with age less than <15 years ",2.3.1.,2.3.1.,2.3.1.,2.3.1.,2.3.1.,2.2.1.,2.3.1.,2.2.1.,2.3.1.,, | |
| ,2.3.2.,"Out of total number of delivery, PW with age 15-19 years ",2.3.2.,2.3.2.,2.3.2.,2.3.2.,2.3.2.,2.2.2.,2.3.2.,2.2.2.,2.3.2.,, | |
| ,2.3.3.,"Out of total number of delivery, PW with age more than >19-49 years ",2.3.3.,2.3.3.,2.3.3.,2.3.3.,2.3.3.,2.2.3.,2.3.3.,2.2.3.,2.3.3.,, | |
| ,2.3.4.,"Out of total number of delivery, PW with age more than > 49 years ",2.3.4.,2.3.4.,2.3.4.,2.3.4.,2.3.4.,2.2.4.,2.3.4.,2.2.4.,2.3.4.,, | |
| ,2.4.,Number of newborns received 6/7 HBNC visits after Delivery (Home+ Institutional) ,2.4.,2.4.,2.4.,2.4.,2.4.,,2.4.,,2.4.,, | |
| ,2.5.,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme ,2.5.,2.5.,2.5.,2.5.,2.5.,,2.5.,,2.5.,, | |
| ,2.6.,Total number of Children received all scheduled 5 Home visits under HBYC ,2.6.,2.6.,2.6.,2.6.,2.6.,,2.6.,,2.6.,, | |
| M3 [Number of Caesarean (C-Section) deliveries],3.1.,Total number of C -Section deliveries performed ,,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,, | |
| ,3.1.1.,"Out of total C-sections, number performed at night (8 PM- 8 AM) ",,3.1.1.,3.1.1.,3.1.1.,3.1.1.,3.1.1,3.1.1.,3.1.1,3.1.1.,, | |
| ,3.1.2.,"Out of total C-section, number of women stayed for 72 hours or more after delivery ",,3.1.2.,3.1.2.,3.1.2.,3.1.2.,3.1.2,3.1.2.,,3.1.2.,, | |
| M4 [Pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male ,3.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,, | |
| ,4.1.1.b,Live Birth - Female ,3.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,, | |
| ,4.1.2.,Number of Pre-term newborns ( < 37 weeks of pregnancy) ,3.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,, | |
| ,4.1.3.a,Fresh Stillbirth - Intrapartum Stillbirth (28 weeks & above) ,3.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,, | |
| ,4.1.3.b,Mascerated Stillbirth – Antepartum Stillbirth (28 weeks &above) ,3.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,, | |
| ,4.1.3.c,Foetal Death (24–27 completed weeks) ,3.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,, | |
| ,4.2.,Abortion (spontaneous) ,3.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,, | |
| ,4.3.1.a,Surgical MTPs upto 12 weeks of pregnancy ,,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,, | |
| ,4.3.1.b,MTP more than 12 weeks of pregnancy ,,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,, | |
| M4 [Pregnancy outcome & details of new-born],4.3.1.c,MTPs completed through Medical methods of abortion (MMA) ,,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,, | |
| ,4.3.2.a,Total Post-abortion/MTP Complications Identified ,3.3.1,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,,4.3.2.a,, | |
| ,4.3.2.b.,Post-abortion/MTP complications identified (where abortions were carried out in facilities other than public and accredited private health facilities) ,3.3.2.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,,4.3.2.b.,, | |
| ,4.3.2.c.,Post-abortion/MTP Complications treated ,,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,,4.3.2.c.,, | |
| ,4.3.3.,Number of women provided with Post-abortion/ MTP contraception ,,4.3.3.,4.3.3.,4.3.3.,4.3.3.,4.3.3.,4.3.3.,,4.3.3.,, | |
| ,4.4.1.,Number of Newborns weighed at birth ,3.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,, | |
| ,4.4.2.,Number of Newborns having weight less than 2500 gms ,3.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,, | |
| ,4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms ",3.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,, | |
| ,4.4.3.,Number of Newborns breast fed within 1 hour of birth ,3.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,, | |
| ,4.4.4.,No. of Newborns discharged from the facility were exclusively breastfed till discharge ,3.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,, | |
| ,4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility ,,,,,4.4.5.,4.4.5,,,,, | |
| ,4.5.1.,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK) ",3.5.1,4.5.1,4.5.1.,4.5.1.,4.5.1,4.5.1.,4.5.1,4.5.1.,4.5.1.,, | |
| ,4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down’s Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip) ",3.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,, | |
| ,4.5.2.,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center,,,,,,,,,,1.1., | |
| ,4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools,,,,,,,,,,1.1.a, | |
| ,4.5.3.,Number of SNCU discharged babies screened in DEIC,,,,4.5.2.,4.5.2.,4.5.2.,,,4.5.2.,, | |
| ,4.5.4.a.1.,Number of children identified with Disease by RBSK Mobile Health teams,,,,,,,,,,1.2.1.a, | |
| M4 [Pregnancy outcome & details of new-born],4.5.4.b.1.,Number of children identified with Deficiency by RBSK Mobile Health teams,,,,,,,,,,1.2.2.a, | |
| ,4.5.4.c.1.,Number of children identified with Developmental delay by RBSK Mobile Health teams,,,,,,,,,,1.2.3.a, | |
| ,4.5.4.d.1.,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,,,,,,,,,,1.2.4.a, | |
| ,4.5.5.,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",,4.5.2,4.5.2.,4.5.3.,4.5.3.,4.5.3.,4.5.2,,4.5.3.,, | |
| ,4.5.6.,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical ,,,,4.5.4.,4.5.4,4.5.4.,,,4.5.4.,, | |
| ,4.5.7.,Number of children till age 18 years managed at DEIC (District Early Intervention Centre) ,,,,,4.5.5.,4.5.5.,,,,, | |
| M5 [Anaemia Mukt Bharat],5.1.1.,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month ",4.1.1.,5.1.1.,5.1.1.,5.1.1.,5.1.1.,,5.1.1.,,5.1.1.,, | |
| ,5.1.2.,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly) ,4.1.2.,5.1.2.,5.1.2.,5.1.2.,5.1.2.,,5.1.2.,,5.1.2.,, | |
| ,5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,4.1.3.a,5.1.3.a,5.1.3.a,5.1.3.a,5.1.3.a,,5.1.3.a,,5.1.3.a,, | |
| ,5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,,,,,,,,,,2.1.1.a, | |
| ,5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dL (deciliter)),,,,,,,,,,2.2.1.a, | |
| ,5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dL (deciliter)),,,,,,,,,,2.2.1.b, | |
| ,5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),4.2.1.a,5.2.1.a,5.2.1.a,5.2.1.a,5.2.1.a,,5.2.1.a,,5.2.1.a,, | |
| ,5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dL (deciliter)),,,,,,,,,,2.2.1.c.i, | |
| M5 [Anaemia Mukt Bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dL (deciliter)),,,,,,,,,,2.2.1.c.ii, | |
| ,5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dL (deciliter)),,,,,,,,,,2.2.1.c.iii, | |
| ,5.2.1.e.,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),4.2.1.b,5.2.1.b,5.2.1.b,5.2.1.b,5.2.1.b,,5.2.1.b,,5.2.1.b,, | |
| ,5.2.1.f.,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl) ",4.2.1.c,5.2.1.c,5.2.1.c,5.2.1.c,5.2.1.c,,5.2.1.c,,5.2.1.c,, | |
| ,5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.a, | |
| ,5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.b, | |
| ,5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),4.2.2.a,5.2.2.a,5.2.2.a,5.2.2.a,5.2.2.a,,5.2.2.a,,5.2.2.a,, | |
| ,5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.c, | |
| ,5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia (Hb <8 g/dl),4.2.2.b,5.2.2.b,5.2.2.b,5.2.2.b,5.2.2.b,,5.2.2.b,,5.2.2.b,, | |
| ,5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",4.2.2.c,5.2.2.c,5.2.2.c,5.2.2.c,5.2.2.c,,5.2.2.c,,5.2.2.c,, | |
| ,5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment ,4.2.3.a,5.2.3.a,5.2.3.a,5.2.3.a,5.2.3.a,,5.2.3.a,,5.2.3.a,, | |
| ,5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,4.2.3.b,5.2.3.b,5.2.3.b,5.2.3.b,5.2.3.b,,5.2.3.b,,5.2.3.b,, | |
| ,5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,4.2.3.c,5.2.3.c,5.2.3.c,5.2.3.c,5.2.3.c,,5.2.3.c,,5.2.3.c,, | |
| ,5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment ,4.2.3.d,5.2.3.d,5.2.3.d,5.2.3.d,5.2.3.d,,5.2.3.d,,5.2.3.d,, | |
| ,5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment ,4.2.3.e,5.2.3.e,5.2.3.e,5.2.3.e,5.2.3.e,,5.2.3.e,,5.2.3.e,, | |
| ,5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment ",4.2.3.f,5.2.3.f,5.2.3.f,5.2.3.f,5.2.3.f,,5.2.3.f,,5.2.3.f,, | |
| ,5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment ,,,5.2.4.a,5.2.4.a,5.2.4.a,5.1.a,,,5.2.4.a,, | |
| M6 [Post Natal Care (PNC)],6.1.,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours ",5.1.,6.1.,6.1.,6.1.,6.1.,,6.1.,,6.1.,, | |
| ,6.2.,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery ,5.2.,6.2.,6.2.,6.2.,6.2.,6.1.,6.2.,,6.2.,, | |
| ,6.3.,Number of mothers provided full course of 180 IFA tablets after delivery ,5.3.,6.3.,6.3.,6.3.,6.3.,6.2.,6.3.,,6.3.,, | |
| ,6.4.,Number of mothers provided full course 360 Calcium tablets after delivery ,5.4.,6.4.,6.4.,6.4.,6.4.,6.3.,6.4.,,6.4.,, | |
| ,6.5.,Total No of High Risk Mothers identified during Post Natal Period ,5.5.,6.5.,6.5.,6.5.,6.5.,6.4.,6.5.,,6.5.,, | |
| ,6.6.,Out of above identified number of High Risk Mothers managed (including referred in cases) ,5.6.,6.6.,6.6.,6.6.,6.6.,6.5.,6.6.,,6.6.,, | |
| M7 [Sexually Transmitted Infections/Reproductive Tract Infections (STI/RTI) Cases],7.1.1.,Number of males assessed for STI/RTI ,6.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,,7.1.1.,, | |
| ,7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI ",6.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,,7.1.1.a,, | |
| ,7.1.1.b,"Out of the above, number of males treated for STI/RTI ",6.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,,7.1.1.b,, | |
| ,7.1.2.,Number of females (all females) assessed for STI/RTI ,6.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,,7.1.2.,, | |
| ,7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI ",6.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,,7.1.2.a,, | |
| ,7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI ",6.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,,7.1.2.b,, | |
| ,7.1.3.,Number of H/TG assessed for STI/RTI ,6.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,,7.1.3.,, | |
| ,7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI ",6.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,,7.1.3.a,, | |
| ,7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI ",6.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,,7.1.3.b,, | |
| M8 [Family Planning],8.1.1.,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted ,,8.1.1.,8.1.1.,8.1.1.,8.1.1.,8.1.1.,8.1.1.,5.1.1.,8.1.1.,, | |
| ,8.2.1.,Number of Laparoscopic sterilizations (excluding post-abortion) conducted ,,8.2.1.,8.2.1.,8.2.1.,8.2.1.,8.2.1.,8.2.1.,5.2.1.,8.2.1.,, | |
| ,8.2.2.,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted ,,8.2.2.,8.2.2.,8.2.2.,8.2.2.,8.2.2.,8.2.2.,5.2.2.,8.2.2.,, | |
| ,8.2.3.,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted ,,8.2.3.,8.2.3.,8.2.3.,8.2.3.,8.2.3.,8.2.3.,5.2.3.,8.2.3.,, | |
| ,8.2.4.,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted ,,8.2.4.,8.2.4.,8.2.4.,8.2.4.,8.2.4.,8.2.4.,5.2.4.,8.2.4.,, | |
| M8 [Family Planning],8.3.,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD) ,7.1.,8.3.,8.3.,8.3.,8.3.,8.3.,8.3.,5.3.,8.3.,, | |
| ,8.4.,Number of Postpartum (within 48 hours of delivery) IUCD insertions ,7.2.,8.4.,8.4.,8.4.,8.4.,8.4.,8.4.,5.4.,8.4.,, | |
| ,8.5.,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions ,,8.5.,8.5.,8.5.,8.5.,8.5.,8.5.,,8.5.,, | |
| ,8.6.,Number of IUCD Removals ,7.3.,8.6.,8.6.,8.6.,8.6.,8.6.,8.6.,,8.6.,, | |
| ,8.7.,Number of complications following IUCD Insertion ,7.4.,8.7.,8.7.,8.7.,8.7.,8.7.,8.7.,,8.7.,, | |
| ,8.8.1.,Injectable Contraceptive MPA (Intra Muscular) - First Dose ,7.5.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,5.5.1.,8.8.1.,, | |
| ,8.8.2.,Injectable Contraceptive MPA (Sub Cutaneous) - First Dose ,7.5.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,5.5.2.,8.8.2.,, | |
| ,8.9.1.,Injectable Contraceptive MPA (Intra Muscular) - Second Dose ,7.6.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,5.6.1.,8.9.1.,, | |
| ,8.9.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Second Dose ,7.6.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,5.6.2.,8.9.2.,, | |
| ,8.10.1.,Injectable Contraceptive MPA (Intra Muscular) - Third Dose ,7.7.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,5.7.1.,8.10.1.,, | |
| ,8.10.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Third Dose ,7.7.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,5.7.2.,8.10.2.,, | |
| ,8.11.1.,Injectable Contraceptive MPA (Intra Muscular) - Fourth and above Dose ,7.8.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,5.8.1.,8.11.1.,, | |
| ,8.11.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Fourth and above Dose ,7.8.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,5.8.2.,8.11.2.,, | |
| ,8.12.,Number of Combined Oral Pill cycles distributed to the beneficiary ,7.9.,8.12.,8.12.,8.12.,8.12.,8.12.,8.12.,,8.12.,, | |
| ,8.13.,Number of Condom pieces distributed to the beneficiary ,7.10.,8.13.,8.13.,8.13.,8.13.,8.13.,8.13.,,8.13.,, | |
| ,8.14.,Number of Centchroman (weekly) pill strips distributed to the beneficiary ,7.11.,8.14.,8.14.,8.14.,8.14.,8.14.,8.14.,,8.14.,, | |
| ,8.15.,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary ,7.12.,8.15.,8.15.,8.15.,8.15.,8.15.,8.15.,,8.15.,, | |
| ,8.16.,Number of Pregnancy Test Kits (PTK) utilized ,7.13.,8.16.,8.16.,8.16.,8.16.,8.16.,8.16.,,8.16.,, | |
| ,8.17.1,No. of Subdermal Contraceptive Implant inserted ,7.14.1.,8.17.1,8.17.1,8.17.1.,8.17.1,8.17.1.,8.17.1,,8.17.1.,, | |
| ,8.17.2,No. of Subdermal Contraceptive Implant removed ,7.14.2.,8.17.2,8.17.2,8.17.2.,8.17.2,8.17.2.,8.17.2,,8.17.2.,, | |
| ,8.18.1.,Complications following male sterilization ,7.15.1.,8.18.1,8.18.1.,8.18.1.,8.18.1.,8.18.1.,8.18.1,,8.18.1.,, | |
| ,8.18.2.,Complications following female sterilization ,7.15.2.,8.18.2,8.18.2.,8.18.2.,8.18.2.,8.18.2.,8.18.2,,8.18.2.,, | |
| M8 [Family Planning],8.18.3.,Failures following male sterilization ,,8.18.3,8.18.3.,8.18.3.,8.18.3.,8.18.3.,8.18.3,,8.18.3.,, | |
| ,8.18.4.,Failures following female sterilization ,,8.18.4,8.18.4.,8.18.4.,8.18.4.,8.18.4.,8.18.4,,8.18.4.,, | |
| ,8.18.5.,Deaths following male sterilization ,,8.18.5,8.18.5.,8.18.5.,8.18.5.,8.18.5.,8.18.5,,8.18.5.,, | |
| ,8.18.6.,Deaths following female sterilization ,,8.18.6,8.18.6.,8.18.6.,8.18.6.,8.18.6.,8.18.6,,8.18.6.,, | |
| ,8.19.1.,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier) ,,8.19.1,8.19.1,8.19.1.,8.19.1,8.19.1.,8.19.1,,8.19.1.,, | |
| ,8.19.2.,Number of cases of Male Sterilization followed up (after 3 months) ,,8.19.2,8.19.2,8.19.2.,8.19.2,8.19.2.,8.19.2,,8.19.2.,, | |
| M9 [CHILD IMMUNISATION],9.1.1.,Child immunisation - Vitamin K (Birth Dose) ,8.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,6.1.1.,9.1.1.,, | |
| ,9.1.2.,Child immunisation - BCG ,8.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,6.1.2.,9.1.2.,, | |
| ,9.1.3.,Child immunisation - Pentavalent 1 ,8.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,6.1.3.,9.1.3.,, | |
| ,9.1.4.,Child immunisation - Pentavalent 2 ,8.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,6.1.4.,9.1.4.,, | |
| ,9.1.5.,Child immunisation - Pentavalent 3 ,8.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,6.1.5.,9.1.5.,, | |
| ,9.1.6.,Child immunisation - OPV 0 (Birth Dose) ,8.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,6.1.6.,9.1.6.,, | |
| ,9.1.7.,Child immunisation - OPV1 ,8.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,6.1.7.,9.1.7.,, | |
| ,9.1.8.,Child immunisation - OPV2 ,8.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,6.1.8.,9.1.8.,, | |
| ,9.1.9.,Child immunisation - OPV3 ,8.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,6.1.9.,9.1.9.,, | |
| ,9.1.10.,Child immunisation - Hepatitis-B0 (Birth Dose) ,8.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,6.1.10.,9.1.10.,, | |
| ,9.1.11.,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1) ,8.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,6.1.11.,9.1.11.,, | |
| ,9.1.12.,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,8.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,6.1.12.,9.1.12.,, | |
| ,9.1.13.,Child immunisation - Rotavirus 1 ,8.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,6.1.13.,9.1.13.,, | |
| ,9.1.14.,Child immunisation - Rotavirus 2 ,8.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,6.1.14.,9.1.14.,, | |
| ,9.1.15.,Child immunisation - Rotavirus 3 ,8.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,6.1.15.,9.1.15.,, | |
| ,9.1.16.,Child immunisation - PCV1 ,8.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,6.1.16.,9.1.16.,, | |
| ,9.1.17.,Child immunisation - PCV2 ,8.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,6.1.17.,9.1.17.,, | |
| ,9.2.1.,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3) ,8.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,6.2.1.,9.2.1.,, | |
| ,9.2.2.,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose ,8.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,6.2.2.,9.2.2.,, | |
| ,9.2.3.,Child immunisation (9-11months) - JE 1st dose ,8.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,6.2.3.,9.2.3.,, | |
| ,9.2.4.,Child immunisation - PCV Booster ,8.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,6.2.4.,9.2.4.,, | |
| M9 [CHILD IMMUNISATION],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male ,8.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,6.2.5.a,9.2.5.a,, | |
| ,9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female ,8.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,6.2.5.b,9.2.5.b,, | |
| ,9.3.1.,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose ,8.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,,9.3.1.,, | |
| ,9.3.2.,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose ,8.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,,9.3.2.,, | |
| ,9.3.3.,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,8.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,,9.3.3.,, | |
| ,9.3.4.,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,8.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,,9.3.4.,, | |
| ,9.3.5.,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,8.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,,9.3.5.,, | |
| ,9.3.6.,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,8.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,,9.3.6.,, | |
| ,9.3.7.,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,8.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,,9.3.7.,, | |
| ,9.3.8.,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,8.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,,9.3.8.,, | |
| ,9.4.1.,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months) ,8.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,6.3.1.,9.4.1.,, | |
| ,9.4.2.,Child immunisation - DPT 1st Booster ,8.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,6.3.2.,9.4.2.,, | |
| ,9.4.3.,Child immunisation - OPV Booster ,8.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,6.3.3.,9.4.3.,, | |
| ,9.4.4.,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months) ,8.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,6.3.4.,9.4.4.,, | |
| ,9.5.1.,Child Immunization- Typhoid ,8.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,,9.5.1.,, | |
| ,9.5.2.,Children more than 5 years received DPT5 (2nd Booster) ,8.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,6.4.1.,9.5.2.,, | |
| ,9.5.3.,Children more than 10 years received Td10 (Tetanus Diptheria10) ,8.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,6.4.2.,9.5.3.,, | |
| ,9.5.4.,Children more than 16 years received Td16 (Tetanus Diptheria16) ,8.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,6.4.3.,9.5.4.,, | |
| ,9.6.1.,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc) ",8.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,,9.6.1.,, | |
| ,9.6.2.,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.) ",8.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,,9.6.2.,, | |
| M9 [CHILD IMMUNISATION],9.6.3.,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.) ",8.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,6.5.1.,9.6.3.,, | |
| ,9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths ",8.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,6.5.1.a,9.6.3.a,, | |
| ,9.7.1.,Immunisation sessions planned ,8.7.1.,9.7.1.,9.7.1.,9.7.1.,9.7.1.,,9.7.1.,,9.7.1.,, | |
| ,9.7.2.,Immunisation sessions held ,8.7.2.,9.7.2.,9.7.2.,9.7.2.,9.7.2.,,9.7.2.,,9.7.2.,, | |
| ,9.8.1.,Child immunisation - Vitamin A Dose - 1 ,8.8.1.,9.8.1.,9.8.1.,9.8.1.,9.8.1.,9.7.1.,9.8.1.,6.6.1.,9.8.1.,, | |
| ,9.8.2.,Child immunisation - Vitamin A Dose - 5 ,8.8.2.,9.8.2.,9.8.2.,9.8.2.,9.8.2.,9.7.2.,9.8.2.,6.6.2.,9.8.2.,, | |
| ,9.8.3.,Child immunisation - Vitamin A Dose - 9 ,8.8.3.,9.8.3.,9.8.3.,9.8.3.,9.8.3.,9.7.3.,9.8.3.,6.6.3.,9.8.3.,, | |
| M10 [Number of cases of Childhood Diseases],10.1.1.,Childhood Diseases - Pneumonia ,,10.1.1.,10.1.1.,10.1.1.,10.1.1.,10.1.1.,10.1.1.,,10.1.1.,, | |
| ,10.1.2.,Childhood Diseases - Asthma ,,10.1.2.,10.1.2.,10.1.2.,10.1.2.,10.1.2.,10.1.2.,,10.1.2.,, | |
| ,10.1.3.,Childhood Diseases - Sepsis ,,10.1.3.,10.1.3.,10.1.3.,10.1.3.,10.1.3.,10.1.3.,,10.1.3.,, | |
| ,10.1.4.,Childhood Diseases - Diphtheria ,,10.1.4.,10.1.4.,10.1.4.,10.1.4.,10.1.4.,10.1.4.,,10.1.4.,, | |
| ,10.1.5.,Childhood Diseases - Pertussis ,,10.1.5.,10.1.5.,10.1.5.,10.1.5.,10.1.5.,10.1.5.,,10.1.5.,, | |
| ,10.1.6.,Childhood Diseases - Tetanus Neonatorum ,,10.1.6.,10.1.6.,10.1.6.,10.1.6.,10.1.6.,10.1.6.,,10.1.6.,, | |
| ,10.1.7.,Childhood Diseases - Tuberculosis (TB) ,,10.1.7.,10.1.7.,10.1.7.,10.1.7.,10.1.7.,10.1.7.,,10.1.7.,, | |
| ,10.1.8.,Childhood Diseases - Acute Flaccid Paralysis(AFP) ,,10.1.8.,10.1.8.,10.1.8.,10.1.8.,10.1.8.,10.1.8.,,10.1.8.,, | |
| ,10.1.9.,Childhood Diseases - Measles ,,10.1.9.,10.1.9.,10.1.9.,10.1.9.,10.1.9.,10.1.9.,,10.1.9.,, | |
| ,10.1.10.,Childhood Diseases - Malaria ,9.1.1.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,,10.1.10.,, | |
| ,10.1.11.,Childhood Diseases - Diarrhoea ,9.1.2.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,,10.1.11.,, | |
| ,10.1.12.,Childhood Diseases - Diarrhoea treated with ORS ,9.1.3.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,,10.1.12.,, | |
| ,10.1.13.,Childhood Diseases - Diarrhoea treated with Zinc for 14 days ,9.1.4.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,,10.1.13.,, | |
| ,10.1.14.,Childhood Diseases -Leprosy Cases ,,10.1.14.,10.1.14.,10.1.14.,10.1.14.,10.1.14.,10.1.14.,,10.1.14.,, | |
| M10 [Number of cases of Childhood Diseases],10.1.15.,Childhood Diseases- Leprosy with Grade II disability ,,10.1.15.,10.1.15.,10.1.15.,10.1.15.,10.1.15.,10.1.15.,,10.1.15.,, | |
| ,10.2.1.,Children admitted with Respiratory Infections ,,10.2.1.,10.2.1.,10.2.1.,10.2.1.,10.2.1.,10.2.1.,,10.2.1.,, | |
| ,10.2.2.,Children admitted with Pneumonia ,,10.2.2.,10.2.2.,10.2.2.,10.2.2.,10.2.2.,10.2.2.,,10.2.2.,, | |
| ,10.2.3.,Children admitted with Diarrhoea ,,10.2.3.,10.2.3.,10.2.3.,10.2.3.,10.2.3.,10.2.3.,,10.2.3.,, | |
| M11 [NVBDCP],11.1.1.a,Total Blood Smears Examined for Malaria ,,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,,11.1.1.a,, | |
| ,11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive ,,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,,11.1.1.b,, | |
| M11 [NVBDCP],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive ,,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,,11.1.1.c,, | |
| ,11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive ,,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,,11.1.1.d,, | |
| ,11.1.2.a,RDT conducted for Malaria ,10.1.1.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,,11.1.2.a,, | |
| ,11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive ,10.1.1.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,,11.1.2.b,, | |
| ,11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive ,10.1.1.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,,11.1.2.c,, | |
| ,11.1.2.d,Malaria (RDT) - Mixed test positive ,10.1.1.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,,11.1.2.d,, | |
| ,11.2.1.,Kala Azar (RDT) - Tests Conducted ,,11.2.1.,11.2.1.,11.2.1.,11.2.1.,11.2.1.,11.2.1.,,11.2.1.,, | |
| ,11.2.2.,Kala Azar Positive Cases ,,11.2.2.,11.2.2.,11.2.2.,11.2.2.,11.2.2.,11.2.2.,,11.2.2.,, | |
| ,11.3.1.,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted ,,,,11.3.1.,11.3.1.,11.3.1.,,,11.3.1.,, | |
| ,11.3.2.,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive ,,,,11.3.2.,11.3.2.,11.3.2.,,,11.3.2.,, | |
| ,11.3.3.,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted ,,,,11.3.3.,11.3.3.,11.3.3.,,,11.3.3.,, | |
| ,11.3.4.,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive ,,,,11.3.4.,11.3.4.,11.3.4.,,,11.3.4.,, | |
| ,11.4.1.,No. of AES cases tested for JE(IgM ELISA) ,,,,11.4.1.,11.4.1.,11.4.1.,,,11.4.1.,, | |
| ,11.4.2.,No. of JE positive cases ,,,,11.4.2.,11.4.2.,11.4.2.,,,11.4.2.,, | |
| ,11.5.1.,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,10.2.1.,11.3.1.,11.3.1.,11.5.1.,11.5.1.,11.5.1.,11.3.1.,,11.5.1.,, | |
| ,11.5.2.,Number of Lymphatic Filarisis lymphoedema patients received MMDP (Morbidity Management And Disability Prevention) kits ,10.2.2.,11.3.2.,11.3.2.,11.5.2.,11.5.2.,11.5.2.,11.3.2.,,11.5.2.,, | |
| ,11.5.3.,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP) ,,,11.3.3.,11.5.3.,11.5.3.,11.5.3.,,,11.5.3.,, | |
| M12 [Adolescent Health],12.1.1.a,Girls registered in AFHC ,,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,,12.1.1.a,, | |
| ,12.1.1.b,Boys registered in AFHC ,,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,,12.1.1.b,, | |
| ,12.1.2.a,"Out of Girls registered, Girls received clinical services ",,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,,12.1.2.a,, | |
| ,12.1.2.b,"Out of Boys registered, Boys received clinical services ",,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,,12.1.2.b,, | |
| ,12.1.3.a,"Out of Girls registered, Girls received counselling ",,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,,12.1.3.a,, | |
| ,12.1.3.b,"Out of Boys registered, Boys received counselling ",,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,,12.1.3.b,, | |
| ,12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,,,,,,,,,,2.3.1.a, | |
| M12 [Adolescent Health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,,,,,,,,,,2.3.1.b, | |
| ,12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,,,,,,,,,,2.3.2.a, | |
| ,12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,,,,,,,,,,2.3.2.b, | |
| ,12.2.3.,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,,,,,,,,,,2.3.3., | |
| ,12.2.4.,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,,,,,,,,,,2.3.4., | |
| ,12.3.1.,Number of adolescent girls provided sanitary napkin packs by ASHA,11.1.1.,12.2.1.,12.2.1.,12.2.1,12.2.1,,12.2.1.,,12.2.1,, | |
| ,12.3.2.,Number of sanitary napkin packs distributed free to ASHA (for her personal use) ,11.1.2.,12.2.2.,12.2.2.,12.2.2,12.2.2,,12.2.2.,,12.2.2,, | |
| ,12.3.3.,Number of adolescent girls attended monthly meeting ,11.1.3.,12.2.3.,12.2.3.,12.2.3,12.2.3,,12.2.3.,,12.2.3,, | |
| ,12.3.4.,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS) ,11.1.4.,12.2.4.,12.2.4.,12.2.4,12.2.4,,12.2.4.,,12.2.4,, | |
| ,12.4.1.,Number of Peer Educators selected ,11.2.1.,12.3.1.,,,,,12.3.1.,,,, | |
| ,12.4.2.,"Out of the selected Peer Educators, numbers trained ",11.2.2.,12.3.2.,,,,,12.3.2.,,,, | |
| ,12.4.3.,Number of Adolescent Health & Wellness Days organized ,11.2.3.,12.3.3.,12.3.1.,12.3.1.,12.3.1.,,12.3.3.,,12.3.1.,, | |
| ,12.4.4.,Number of Adolescent Friendly Club Meetings organized ,11.2.4.,12.3.4.,,,,,12.3.4.,,,, | |
| M13 [National TB Elimination Programme (NTEP)],13.1.,Number of beneficiaries who are registered at the ICTC centre. ,,,13.1.,13.1.,13.1.,13.1.,,,13.1.,, | |
| ,13.2.,"Of the number registered at ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis ",,,13.2.,13.2.,13.2.,13.2.,,,13.2.,, | |
| ,13.3.,Number of beneficiaries who are registered at the NCD clinic. ,,,13.3.,13.3.,13.3.,13.3.,,,13.3.,, | |
| ,13.4.,The number registered at the NCD clinic includes the number of presumptive TB cases identified and referred for TB testing and diagnosis ,,,13.4.,13.4.,13.4.,13.4.,,,13.4.,, | |
| M14 [Patient Services],14.1.1.a,Total number of geriatric/elderly patients (age>=60 yrs) Registered ,12.1.1.a,13.1.1.a,14.1.1.a,14.1.1.a,14.1.1.a,14.1.1.a,13.1.1.a,,14.1.1.a,, | |
| ,14.1.1.b,Geriatric (age>=60 yrs) patients footfall ,12.1.1.b,13.1.1.b,14.1.1.b,14.1.1.b,14.1.1.b,14.1.1.b,13.1.1.b,,14.1.1.b,, | |
| ,14.1.1.c,Number of geriatric/elderly persons who underwent Comprehensive Geriatric Assessment by CHO ,12.1.1.c,13.1.1.c,,,,,13.1.1.c,,,, | |
| ,14.1.1.d,Number of geriatric/elderly persons managed for any elderly conditions ,12.1.1.d,13.1.1.d,14.1.1.c,14.1.1.c,14.1.1.c,14.1.1.c,13.1.1.d,,14.1.1.c,, | |
| ,14.1.1.e,Number of geriatric/elderly persons followed-up for any elderly conditions ,12.1.1.e,13.1.1.e,14.1.1.d,14.1.1.d,14.1.1.d,14.1.1.d,13.1.1.e,,14.1.1.d,, | |
| ,14.1.1.f,Number of geriatric/elderly patients (age>=60 yrs) provided physiotherapy services ,12.1.1.f,13.1.1.f,14.1.1.e,14.1.1.e,14.1.1.e,14.1.1.e,13.1.1.f,,14.1.1.e,, | |
| ,14.1.1.g,Number of home bound (bed bound & restricted mobility) elderly and single elderly visited by ASHA & ANM/MPW-M during the month ,12.1.1.g,13.1.1.g,14.1.1.f,14.1.1.f,14.1.1.f,,13.1.1.g,,14.1.1.f,, | |
| M14 [Patient Services],14.1.1.h,Number of elderly support groups-‘Sanjeevini’ created during the month ,12.1.1.h,13.1.1.h,,,,,13.1.1.h,,,, | |
| ,14.1.1.i,Number of weekly geriatric clinics organized during the month ,12.1.1.i,13.1.1.i,,,,,13.1.1.i,,,, | |
| ,14.1.1.j,Number of fixed day rehabilitation services provided during the month ,12.1.1.j,13.1.1.j,,,,,13.1.1.j,,,, | |
| ,14.1.2.a.,Number of patients provided physiotherapy services ,,13.1.2.a,14.1.2.a,14.1.2.a,14.1.2.a,14.1.2.a,13.1.2.a,,14.1.2.a,, | |
| ,14.1.2.b.,Number of Palliative Patients visited at home ,12.1.2.a,13.1.2.b,14.1.2.b,14.1.2.b,14.1.2.b,,13.1.2.b,,14.1.2.b,, | |
| ,14.1.2.c.,Number of visits for home care/ end of life care provided by AAM-PHC team ,,13.1.2.c,,,,,13.1.2.c,,,, | |
| ,14.1.2.d.,Number of weekly palliative care OPD conducted at AAM-PHC ,12.1.2.b,13.1.2.d,,,,,13.1.2.d,,,, | |
| ,14.1.2.e.,Number of cases reported for Self Harm ,12.1.2.c,13.1.2.e,14.1.2.c,14.1.2.c,14.1.2.c,14.1.2.b,13.1.2.e,,14.1.2.c,, | |
| ,14.1.3.a,Total number of footfall in outreach camps/sessions ,12.1.3.a.,13.1.3.a,14.1.3.a,14.1.3.a,14.1.3.a,,13.1.3.a,,14.1.3.a,, | |
| ,14.1.3.b,Total number cases examined in outreach camps for Mental illness ,12.1.3.b.,13.1.3.b,14.1.3.b,14.1.3.b,14.1.3.b,,13.1.3.b,,14.1.3.b,, | |
| ,14.1.4.,Number of psychoeducation sessions conducted at the Ayushman Arogya Mandir during the month ,12.1.4.,13.1.3.c,,,,,13.1.3.c,,,, | |
| ,14.2.1.,Allopathic- Outpatient attendance ,12.2.1.,13.2.1.,14.2.1.,14.2.1.,14.2.1.,14.2.1.,13.2.1.,7.1.1.,14.2.1.,, | |
| ,14.2.1.a,"Out of above, number of specialist Allopathic OPD services provided ",12.2.1.a,13.2.1.a,14.2.1.a,14.2.1.a,14.2.1.a,14.2.1.a,13.2.1.a,,14.2.1.a,, | |
| ,14.2.2.,Ayush - Outpatient attendance ,12.2.2.,13.2.2.,14.2.2.,14.2.2.,14.2.2.,14.2.2.,13.2.2.,7.1.2.,14.2.2.,, | |
| ,14.2.2.b,"Out of above, number of specialist AYUSH OPD services provided ",12.2.2.a,13.2.2.a,14.2.2.a,14.2.2.a,14.2.2.a,14.2.2.a,13.2.2.a,,14.2.2.a,, | |
| ,14.3.1.a,IPD Admission Male- Children<18yrs ,,13.3.1.a,14.3.1.a,14.3.1.a,14.3.1.a,14.3.1.a,13.3.1.a,7.2.1.a,14.3.1.a,, | |
| ,14.3.1.b,IPD Admission Male- Adults <60yrs ,,13.3.1.b,14.3.1.b,14.3.1.b,14.3.1.b,14.3.1.b,13.3.1.b,7.2.1.b,14.3.1.b,, | |
| ,14.3.1.c,IPD Admission Female- Children<18yrs ,,13.3.1.c,14.3.1.c,14.3.1.c,14.3.1.c,14.3.1.c,13.3.1.c,7.2.1.c,14.3.1.c,, | |
| ,14.3.1.d,IPD Admission Female- Adults<60yrs ,,13.3.1.d,14.3.1.d,14.3.1.d,14.3.1.d,14.3.1.d,13.3.1.d,7.2.1.d,14.3.1.d,, | |
| ,14.3.1.e,IPD Admission Geriatric->=60yrs ,,13.3.1.e,14.3.1.e,14.3.1.e,14.3.1.e,14.3.1.e,13.3.1.e,7.2.1.e,14.3.1.e,, | |
| ,14.3.2.a,IPD Discharge Male- Children<18yrs ,,13.3.2.a,14.3.2.a,14.3.2.a,14.3.2.a,14.3.2.a,13.3.2.a,7.2.2.a,14.3.2.a,, | |
| ,14.3.2.b,IPD Discharge Male- Adults<60yrs ,,13.3.2.b,14.3.2.b,14.3.2.b,14.3.2.b,14.3.2.b,13.3.2.b,7.2.2.b,14.3.2.b,, | |
| ,14.3.2.c,IPD Discharge Female- Children<18yrs ,,13.3.2.c,14.3.2.c,14.3.2.c,14.3.2.c,14.3.2.c,13.3.2.c,7.2.2.c,14.3.2.c,, | |
| ,14.3.2.d,IPD Discharge Female- Adults<60yrs ,,13.3.2.d,14.3.2.d,14.3.2.d,14.3.2.d,14.3.2.d,13.3.2.d,7.2.2.d,14.3.2.d,, | |
| ,14.3.2.e,IPD Discharge Geriatric->=60yrs ,,13.3.2.e,14.3.2.e,14.3.2.e,14.3.2.e,14.3.2.e,13.3.2.e,7.2.2.e,14.3.2.e,, | |
| ,14.3.3.a,IPD Referred Male- Children<18yrs ,,13.3.3.a,14.3.3.a,14.3.3.a,14.3.3.a,14.3.3.a,13.3.3.a,,14.3.3.a,, | |
| ,14.3.3.b,IPD Referred Male- Adults<60yrs ,,13.3.3.b,14.3.3.b,14.3.3.b,14.3.3.b,14.3.3.b,13.3.3.b,,14.3.3.b,, | |
| ,14.3.3.c,IPD Referred Female- Children<18yrs ,,13.3.3.c,14.3.3.c,14.3.3.c,14.3.3.c,14.3.3.c,13.3.3.c,,14.3.3.c,, | |
| ,14.3.3.d,IPD Referred Female- Adults<60yrs ,,13.3.3.d,14.3.3.d,14.3.3.d,14.3.3.d,14.3.3.d,13.3.3.d,,14.3.3.d,, | |
| ,14.3.3.e,IPD Referred Geriatric->=60yrs ,,13.3.3.e,14.3.3.e,14.3.3.e,14.3.3.e,14.3.3.e,13.3.3.e,,14.3.3.e,, | |
| ,14.3.4.a,IPD Deaths Male- Children<18yrs ,,13.3.4.a,14.3.4.a,14.3.4.a,14.3.4.a,14.3.4.a,13.3.4.a,7.2.3.a,14.3.4.a,, | |
| ,14.3.4.b,IPD Deaths Male- Adults<60yrs ,,13.3.4.b,14.3.4.b,14.3.4.b,14.3.4.b,14.3.4.b,13.3.4.b,7.2.3.b,14.3.4.b,, | |
| M14 [Patient Services],14.3.4.c,IPD Deaths Female- Children<18yrs ,,13.3.4.c,14.3.4.c,14.3.4.c,14.3.4.c,14.3.4.c,13.3.4.c,7.2.3.c,14.3.4.c,, | |
| ,14.3.4.d,IPD Deaths Female- Adults<60yrs ,,13.3.4.d,14.3.4.d,14.3.4.d,14.3.4.d,14.3.4.d,13.3.4.d,7.2.3.d,14.3.4.d,, | |
| ,14.3.4.e,IPD Deaths Geriatric->=60yrs ,,13.3.4.e,14.3.4.e,14.3.4.e,14.3.4.e,14.3.4.e,13.3.4.e,7.2.3.e,14.3.4.e,, | |
| ,14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,12.3.1.,13.3.5.a,14.3.5.a,14.3.5.a,14.3.5.a,14.3.5.a,13.3.5.a,7.2.4.a,14.3.5.a,, | |
| ,14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM) ,,13.3.5.b,14.3.5.b,14.3.5.b,14.3.5.b,14.3.5.b,13.3.5.b,7.2.4.b,14.3.5.b,, | |
| ,14.3.6.,Day Care Admissions ,12.4.,13.3.6.,14.3.6.,14.3.6.,14.3.6.,14.3.6.,13.3.6.,7.2.5.,14.3.6.,, | |
| ,14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility ,,13.3.7.a,14.3.7.a,14.3.7.a,14.3.7.a,14.3.7.a,13.3.7.a,,14.3.7.a,, | |
| ,14.3.7.b,Number of delivery LAMA cases reported at the facility ,,13.3.7.b,14.3.7.b,14.3.7.b,14.3.7.b,14.3.7.b,13.3.7.b,,14.3.7.b,, | |
| ,14.3.8,Total number of Medico Legal Cases reported at the facility ,,13.3.8.,14.3.8.,14.3.8.,14.3.8.,14.3.8.,13.3.8.,,14.3.8.,, | |
| ,14.3.9,Total number of postmortem conducted at the facility ,,,14.3.9.,14.3.9.,14.3.9.,14.3.9.,,,14.3.9.,, | |
| ,14.3.10.,Total number of telemedicine consultation provided ,12.5.,13.3.9.,14.3.10.,14.3.10.,14.3.10.,14.3.10.,13.3.9.,,14.3.10.,, | |
| ,14.4.1.,Inpatient - Malaria ,,13.4.1.,14.4.1.,14.4.1.,14.4.1.,14.4.1.,13.4.1.,,14.4.1.,, | |
| ,14.4.2.,Inpatient - Dengue ,,13.4.2.,14.4.2.,14.4.2.,14.4.2.,14.4.2.,13.4.2.,,14.4.2.,, | |
| ,14.4.3.,Inpatient - Typhoid ,,13.4.3.,14.4.3.,14.4.3.,14.4.3.,14.4.3.,13.4.3.,,14.4.3.,, | |
| ,14.4.4.,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections ",,13.4.4.,14.4.4.,14.4.4.,14.4.4.,14.4.4.,13.4.4.,,14.4.4.,, | |
| ,14.4.5.,Inpatient - Tuberculosis ,,13.4.5.,14.4.5.,14.4.5.,14.4.5.,14.4.5.,13.4.5.,,14.4.5.,, | |
| ,14.4.6.,Inpatient - Pyrexia of unknown origin (PUO) ,,13.4.6.,14.4.6.,14.4.6.,14.4.6.,14.4.6.,13.4.6.,,14.4.6.,, | |
| ,14.4.7.,Inpatient - Diarrhoea with dehydration ,,13.4.7.,14.4.7.,14.4.7.,14.4.7.,14.4.7.,13.4.7.,,14.4.7.,, | |
| ,14.4.8.,Inpatient – Leprosy (Reconstructive Surgery) ,,,,14.4.8.,14.4.8.,14.4.8.,,,14.4.8.,, | |
| ,14.4.9.,Inpatient – Operated for Cataract ,,,14.4.8.,14.4.9.,14.4.9.,14.4.9.,,,14.4.9.,, | |
| ,14.4.10.,Inpatient – Palliative Care ,,13.4.8.,14.4.9.,14.4.10.,14.4.10.,14.4.10.,13.4.8.,,14.4.10.,, | |
| ,14.4.11.,Inpatient – Mental illness ,,,,,14.4.11.,14.4.11.,,,,, | |
| ,14.5.1.,Patients registered at Emergency Department ,,13.5.1.,14.5.1.,14.5.1.,14.5.1.,14.5.1.,13.5.1.,,14.5.1.,, | |
| ,14.5.2.,No. of Emergencies managed at night (8 PM- 8 AM) ,,13.5.2.,14.5.2.,14.5.2.,14.5.2.,14.5.2.,13.5.2.,,14.5.2.,, | |
| ,14.5.3.,Total Number of Emergency cases managed ,12.6.1.,13.5.3.,14.5.3.,14.5.3.,14.5.3.,14.5.3.,13.5.3.,,14.5.3.,, | |
| ,14.5.4.,Total Number of Emergency cases referred out ,,13.5.4.,14.5.4.,14.5.4.,14.5.4.,14.5.4.,13.5.4.,,14.5.4.,, | |
| ,14.5.5.,Total Number of CPR performed in the emergency ,12.6.2.,13.5.5.,14.5.5.,14.5.5.,14.5.5.,14.5.5.,13.5.5.,,14.5.5.,, | |
| ,14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission ",,13.6.1.a,14.6.1.a,14.6.1.a,14.6.1.a,14.6.1.a,13.6.1.a,,14.6.1.a,, | |
| ,14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths ",,13.6.1.b,14.6.1.b,14.6.1.b,14.6.1.b,14.6.1.b,13.6.1.b,,14.6.1.b,, | |
| ,14.6.2.a,Emergency - Burn -Admission ,,13.6.2.a,14.6.2.a,14.6.2.a,14.6.2.a,14.6.2.a,13.6.2.a,,14.6.2.a,, | |
| ,14.6.2.b,Emergency - Burn -Deaths ,,13.6.2.b,14.6.2.b,14.6.2.b,14.6.2.b,14.6.2.b,13.6.2.b,,14.6.2.b,, | |
| ,14.6.3.a,Emergency - Obstetrics complications -Admission ,,13.6.3.a,14.6.3.a,14.6.3.a,14.6.3.a,14.6.3.a,13.6.3.a,,14.6.3.a,, | |
| ,14.6.3.b,Emergency - Obstetrics complications -Deaths ,,13.6.3.b,14.6.3.b,14.6.3.b,14.6.3.b,14.6.3.b,13.6.3.b,,14.6.3.b,, | |
| ,14.6.4.a,Emergency - Snake Bite -Admission ,,13.6.4.a,14.6.4.a,14.6.4.a,14.6.4.a,14.6.4.a,13.6.4.a,,14.6.4.a,, | |
| M14 [Patient Services],14.6.4.b,Emergency - Snake Bite -Deaths ,,13.6.4.b,14.6.4.b,14.6.4.b,14.6.4.b,14.6.4.b,13.6.4.b,,14.6.4.b,, | |
| ,14.6.5.a,Emergency - Acute Cardiac Emergencies -Admission ,,13.6.5.a,14.6.5.a,14.6.5.a,14.6.5.a,14.6.5.a,13.6.5.a,,14.6.5.a,, | |
| ,14.6.5.b,Emergency - Acute Cardiac Emergencies -Deaths ,,13.6.5.b,14.6.5.b,14.6.5.b,14.6.5.b,14.6.5.b,13.6.5.b,,14.6.5.b,, | |
| ,14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission ,,13.6.6.a,14.6.6.a,14.6.6.a,14.6.6.a,14.6.6.a,13.6.6.a,,14.6.6.a,, | |
| ,14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths ,,13.6.6.b,14.6.6.b,14.6.6.b,14.6.6.b,14.6.6.b,13.6.6.b,,14.6.6.b,, | |
| ,14.6.7.a,Emergency - Dog Bite -Admission ,,13.6.7.a,14.6.7.a,14.6.7.a,14.6.7.a,14.6.7.a,13.6.7.a,,14.6.7.a,, | |
| ,14.6.7.b,Emergency - Dog Bite -Deaths ,,13.6.7.b,14.6.7.b,14.6.7.b,14.6.7.b,14.6.7.b,13.6.7.b,,14.6.7.b,, | |
| ,14.7.,Total number of deaths occurring at Emergency Department ,,13.7.,14.7.,14.7.,14.7.,14.7.,13.7.,,14.7.,, | |
| ,14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia) ,,,14.8.1.a,14.8.1.a,14.8.1.a,14.8.1.a,,7.3.1.,14.8.1.a,, | |
| ,14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries ",,,14.8.1.b,14.8.1.b,14.8.1.b,14.8.1.b,,,14.8.1.b,, | |
| ,14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology. ",,,,14.8.1.c,14.8.1.c,14.8.1.c,,,14.8.1.c,, | |
| ,14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,,,14.8.1.c,14.8.1.d,14.8.1.d,14.8.1.d,,,14.8.1.d,, | |
| ,14.8.2.,Minor Operations (No or local anaesthesia) ,,13.8.,14.8.2.,14.8.2.,14.8.2.,14.8.2.,13.8.,7.3.2.,14.8.2.,, | |
| ,14.9.,Number of post operative Surgical Site infection ,,,14.8.3.,14.8.3.,14.8.3.,14.8.3.,,,14.8.3.,, | |
| ,14.10.,In-Patient Head Count at midnight ,,13.9.,14.9.,14.9.,14.9.,14.9.,13.9.,7.4.,14.9.,, | |
| ,14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit) ,,13.10.1.,14.10.1.,14.10.1.,14.10.1,,13.10.1.,,14.10.1.,, | |
| ,14.11.2.,Number of total admissions in Special Newborn Care Unit (SNCU Admissions) ,,,14.10.2.,14.10.2.,14.10.2.,14.10.1.,,,14.10.2.,, | |
| ,14.12.1,Number of deaths occurred at SNCU ,,,14.11.1.,14.11.1.,14.11.1,14.11.1,,,14.11.1.,, | |
| ,14.12.2,Number of Newborns successfully discharged from SNCU ,,,14.11.2.,14.11.2.,14.11.2,14.11.2,,,14.11.2.,, | |
| ,14.13.1.a.i,Number of pregnant women provided free medicines during ANC period under JSSK ,12.7.1.a.i,13.11.1.a.i,14.12.1.a.i,14.12.1.a.i,14.12.1.a.i,14.12.1.a.i,13.11.1.a.i,,14.12.1.a.i,, | |
| ,14.13.1.a.ii,Number of Pregnant women provided free medicines during delivery under JSSK ,12.7.1.a.ii,13.11.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,13.11.1.a.ii,,14.12.1.a.ii,, | |
| ,14.13.1.a.iii,Number of PNC mothers provided free medicines under JSSK ,12.7.1.a.iii,13.11.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,13.11.1.a.iii,,14.12.1.a.iii,, | |
| ,14.13.1.b,Number of women provided - Free Diet under JSSK ,12.7.1.b.,13.11.1.b,14.12.1.b,14.12.1.b,14.12.1.b,14.12.1.b,13.11.1.b,,14.12.1.b,, | |
| ,14.13.1.c.i,Number of pregnant women provided free diagnostics during ANC period under JSSK ,12.7.1.c.i,13.11.1.c.i,14.12.1.c.i,14.12.1.c.i,14.12.1.c.i,14.12.1.c.i,13.11.1.c.i,,14.12.1.c.i,, | |
| ,14.13.1.c.ii,Number of Pregnant women provided free diagnostics during delivery under JSSK ,12.7.1.c.ii,13.11.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,13.11.1.c.ii,,14.12.1.c.ii,, | |
| ,14.13.1.c.iii,Number of PNC mothers provided free diagnostics under JSSK ,12.7.1.c.iii,13.11.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,13.11.1.c.iii,,14.12.1.c.iii,, | |
| ,14.13.1.d,Number ofpregnant women provided - Free Home to facility transport for conducting delivery under JSSK ,12.7.1.d,13.11.1.d,14.12.1.d,14.12.1.d,14.12.1.d,14.12.1.d,13.11.1.d,,14.12.1.d,, | |
| ,14.13.1.e,Number of pregnant women provided - Interfacility transfers when needed during delivery under JSSK(in case of referral) ,12.7.1.e,13.11.1.e,14.12.1.e,14.12.1.e,14.12.1.e,14.12.1.e,13.11.1.e,,14.12.1.e,, | |
| M14 [Patient Services],14.13.1.f,Number of PNC mothers provided - Free Drop Back home after delivery under JSSK ,12.7.1.f,13.11.1.f,14.12.1.f,14.12.1.f,14.12.1.f,14.12.1.f,13.11.1.f,,14.12.1.f,, | |
| ,14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries ,12.7.2.a,13.11.2.a,14.12.2.a,14.12.2.a,14.12.2.a,14.12.2.a,13.11.2.a,,14.12.2.a,, | |
| ,14.13.2.b,Number of sick infants provided - Free Medicines under JSSK ,12.7.2.b,13.11.2.b,14.12.2.b,14.12.2.b,14.12.2.b,14.12.2.b,13.11.2.b,,14.12.2.b,, | |
| ,14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK ,,13.11.2.c,14.12.2.c,14.12.2.c,14.12.2.c,14.12.2.c,13.11.2.c,,14.12.2.c,, | |
| ,14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK ,12.7.2.c,13.11.2.d,14.12.2.d,14.12.2.d,14.12.2.d,14.12.2.d,13.11.2.d,,14.12.2.d,, | |
| ,14.13.2.e,Number of infants received free referral transport under JSSK ,12.7.2.d,13.11.2.e,14.12.2.e,14.12.2.e,14.12.2.e,14.12.2.e,13.11.2.e,,14.12.2.e,, | |
| ,14.14.1.,Number of sick SAM children admitted in standalone/ integrated NRC ,,13.12.1.,14.13.1.,14.13.1.,14.13.1.,14.13.1.,13.12.1.,,14.13.1.,, | |
| ,14.14.2.,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM) ,,13.12.2.,14.13.2.,14.13.2.,14.13.2.,14.13.2.,13.12.2.,,14.13.2.,, | |
| ,14.14.3.,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC) ,,13.12.3.,14.13.3.,14.13.3.,14.13.3.,14.13.3.,13.12.3.,,14.13.3.,, | |
| ,14.14.4.,Number of children Referred to standalone/ integrated NRC by RBSK Team ,,13.12.4.,14.13.4.,14.13.4.,14.13.4.,14.13.4.,13.12.4.,,14.13.4.,, | |
| ,14.14.5.,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria ,,13.12.5.,14.13.5.,14.13.5.,14.13.5.,14.13.5.,13.12.5.,,14.13.5.,, | |
| ,14.14.6.,Number of admitted children left against medical advice (LAMA) / defaulter ,,13.12.6.,14.13.6.,14.13.6.,14.13.6.,14.13.6.,13.12.6.,,14.13.6.,, | |
| ,14.14.7.,Number of children died while admitted in standalone/ intergrated NRC ,,13.12.7.,14.13.7.,14.13.7.,14.13.7.,14.13.7.,13.12.7.,,14.13.7.,, | |
| ,14.14.8.,Number of children who completed all four post discharge follow-ups ,,13.12.8.,14.13.8.,14.13.8.,14.13.8.,14.13.8.,13.12.8.,,14.13.8.,, | |
| ,14.14.9.,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC) ,,13.12.9.,14.13.9.,14.13.9.,14.13.9.,14.13.9.,13.12.9.,,14.13.9.,, | |
| ,14.14.10.,In-Patient Head Count at midnight for standalone/ integrated NRC ,,13.12.10.,14.13.10.,14.13.10.,14.13.10.,14.13.10.,13.12.10.,,14.13.10.,, | |
| ,14.15.1.,Number of Rogi Kalyan Samiti (RKS) meetings held ,,13.13.1.,14.14.,14.14.,14.14.,14.14.,13.13.1.,,14.14.,, | |
| ,14.15.2.,Number of Jan Arogya Samiti (JAS) meetings held ,12.8.,13.13.2.,,,,,13.13.2.,,,, | |
| ,14.16.,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions ,12.9.,13.14.,14.15.,14.15.,14.15.,,13.14.,,14.15.,, | |
| ,14.17.,Total number of UHND/VHND sessions conducted in the reporting month ,12.10.,13.15.,14.16.,14.16.,14.16.,,13.15.,,14.16.,, | |
| ,14.18.,Total number of Outreach/Special Outreach camps conducted in the reporting month ,12.11.,13.16.,14.17.,14.17.,14.17.,,13.16.,,14.17.,, | |
| ,14.18.1.,Total number of outreach visits conducted by staff ,12.11.1.,13.16.1.,14.17.1.,14.17.1.,14.17.1.,,13.16.1.,,14.17.1.,, | |
| ,14.18.2.,Total number of outreach visits made by DMHP team ,,,,14.17.2.,14.17.2.,,,,14.17.2.,, | |
| M14 [Patient Services],14.18.3,Total number of awareness campaigns/camps conducted for Mental Health ,12.11.2.,13.16.2. ,14.17.2. ,14.17.3.,14.17.3.,,13.16.2.,,14.17.3.,, | |
| ,14.19.,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal) ,12.12.,13.17.,14.18.,14.18.,14.18.,,13.17.,,14.18.,, | |
| ,14.20.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV) ,,,,,14.19.1.a,,,,,, | |
| ,14.20.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women) ,12.13.1.a,13.18.1.a,14.19.1.a,14.19.1.a,14.19.1.b,,13.18.1.a,,14.19.1.a,, | |
| ,14.20.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV) ,12.13.1.b,13.18.1.b,14.19.1.b,14.19.1.b,14.19.1.c,,13.18.1.b,,14.19.1.b,, | |
| ,14.20.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV) ,,,,,14.19.1.d,,,,,, | |
| ,14.20.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV) ,,,,,14.19.2.a,,,,,, | |
| ,14.20.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women) ,12.13.2.a,13.18.2.a,14.19.2.a,14.19.2.a,14.19.2.b,,13.18.2.a,,14.19.2.a,, | |
| ,14.20.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,,13.18.2.a.i,14.19.2.a.i,14.19.2.a.i,14.19.2.b.i,,13.18.2.a.i,,14.19.2.a.i,, | |
| ,14.20.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,,13.18.2.a.ii,14.19.2.a.ii,14.19.2.a.ii,14.19.2.b.ii,,13.18.2.a.ii,,14.19.2.a.ii,, | |
| ,14.20.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women) ,,13.18.2.a.iii,14.19.2.a.iii,14.19.2.a.iii,14.19.2.b.iii,,13.18.2.a.iii,,14.19.2.a.iii,, | |
| ,14.20.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV) ,12.13.2.b,13.18.2.b,14.19.2.b,14.19.2.b,14.19.2.c,,13.18.2.b,,14.19.2.b,, | |
| ,14.20.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV) ,,13.18.2.b.i,14.19.2.b.i,14.19.2.b.i,14.19.2.c.i,,13.18.2.b.i,,14.19.2.b.i,, | |
| ,14.20.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected) ,,13.18.2.b.ii,14.19.2.b.ii,14.19.2.b.ii,14.19.2.c.ii,,13.18.2.b.ii,,14.19.2.b.ii,, | |
| ,14.20.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment ,,13.18.2.b.iii,14.19.2.b.iii,14.19.2.b.iii,14.19.2.c.iii,,13.18.2.b.iii,,14.19.2.b.iii,, | |
| ,14.20.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12) ,,13.18.2.b.iv,14.19.2.b.iv,14.19.2.b.iv,14.19.2.c.iv,,13.18.2.b.iv,,14.19.2.b.iv,, | |
| ,14.20.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,,,,,14.19.2.d,,,,,, | |
| ,14.20.3.a,Number of Pregnant Women tested for HBsAg ,12.13.3.a,13.18.3.a,14.19.3.a,14.19.3.a,14.19.3.a,,13.18.3.a,,14.19.3.a,, | |
| ,14.20.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg) ,12.13.3.b,13.18.3.b,14.19.3.b,14.19.3.b,14.19.3.b,,13.18.3.b,7.5.1.a,14.19.3.b,, | |
| M14 [Patient Services],14.20.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery ,12.13.3.c,13.18.3.c,14.19.3.c,14.19.3.c,14.19.3.c,,13.18.3.c,,14.19.3.c,, | |
| ,14.20.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution ,,13.18.3.d,14.19.3.d,14.19.3.d,14.19.3.d,,13.18.3.d,,14.19.3.d,, | |
| ,14.20.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women ,12.13.3.d,13.18.3.e,14.19.3.e,14.19.3.e,14.19.3.e,,13.18.3.e,,14.19.3.e,, | |
| ,14.20.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth) ,,13.18.3.f,14.19.3.f,14.19.3.f,14.19.3.f,,13.18.3.f,7.5.1.b,14.19.3.f,, | |
| M15 [Laboratory Testing],15.1.1.,Total Number of Lab Tests done- Inhouse (including kits tests conducted in Laboratory) ,13.1.1.,14.1.1.,15.1.1.,15.1.1.,15.1.1.,,14.1.1.,8.1.1.,15.1.1.,, | |
| ,15.1.2.,Total Number of Lab Tests done- Outsourced (including kits tests conducted in Laboratory) ,13.1.2.,14.1.2.,15.1.2.,15.1.2.,15.1.2.,,14.1.2.,8.1.2.,15.1.2.,, | |
| ,15.1.3.,Total Number of Kit Tests conducted in Outreach areas/Camps/in-facility(outside lab) ,13.1.3.,14.1.3.,15.1.3.,15.1.3.,15.1.3.,,14.1.3.,,15.1.3.,, | |
| ,15.2.1.,Number of Hb tests conducted including kit tests ,13.2.1.,14.2.1,15.2.1.,15.2.1.,15.2.1.,,14.2.1,,15.2.1.,, | |
| ,15.2.2.,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",13.2.2.,14.2.2,15.2.2.,15.2.2.,15.2.2.,,14.2.2,,15.2.2.,, | |
| ,15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.1.a,14.3.1.a,15.3.1.a,15.3.1.a,15.3.1.a,,14.3.1.a,,15.3.1.a,, | |
| ,15.3.1.b,"Out of the above, No. of males found reactive for HIV ",13.3.1.b,14.3.1.b,15.3.1.b,15.3.1.b,15.3.1.b,,14.3.1.b,,15.3.1.b,, | |
| ,15.3.1.c,No. of males subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.1.c,14.3.1.c,15.3.1.c,15.3.1.c,15.3.1.c,,14.3.1.c,,15.3.1.c,, | |
| ,15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",13.3.1.d,14.3.1.d,15.3.1.d,15.3.1.d,15.3.1.d,,14.3.1.d,,15.3.1.d,, | |
| ,15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.2.a,14.3.2.a,15.3.2.a,15.3.2.a,15.3.2.a,,14.3.2.a,,15.3.2.a,, | |
| ,15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV ",13.3.2.b,14.3.2.b,15.3.2.b,15.3.2.b,15.3.2.b,,14.3.2.b,,15.3.2.b,, | |
| ,15.3.2.c,No. of females (non-ANC) subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.2.c,14.3.2.c,15.3.2.c,15.3.2.c,15.3.2.c,,14.3.2.c,,15.3.2.c,, | |
| ,15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",13.3.2.d,14.3.2.d,15.3.2.d,15.3.2.d,15.3.2.d,,14.3.2.d,,15.3.2.d,, | |
| ,15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.3.a,14.3.3.a,15.3.3.a,15.3.3.a,15.3.3.a,,14.3.3.a,,15.3.3.a,, | |
| ,15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV ",13.3.3.b,14.3.3.b,15.3.3.b,15.3.3.b,15.3.3.b,,14.3.3.b,,15.3.3.b,, | |
| ,15.3.3.c,No. of PW(ANC) subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.3.c,14.3.3.c,15.3.3.c,15.3.3.c,15.3.3.c,,14.3.3.c,,15.3.3.c,, | |
| ,15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",13.3.3.d,14.3.3.d,15.3.3.d,15.3.3.d,15.3.3.d,,14.3.3.d,,15.3.3.d,, | |
| ,15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,,14.3.3.e,15.3.3.e,15.3.3.e,15.3.3.e,,14.3.3.e,,15.3.3.e,, | |
| ,15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV ",,14.3.3.f,15.3.3.f,15.3.3.f,15.3.3.f,,14.3.3.f,,15.3.3.f,, | |
| ,15.3.3.g,No. of DIL women subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,,,,15.3.3.g,15.3.3.g,,,,15.3.3.g,, | |
| M15 [Laboratory Testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",,,,15.3.3.h,15.3.3.h,,,,15.3.3.h,, | |
| ,15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,13.3.3.e,14.3.3.g,15.3.3.g,15.3.3.i,15.3.3.i,,14.3.3.g,,15.3.3.i,, | |
| ,15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.4.a,14.3.4.a,15.3.4.a,15.3.4.a,15.3.4.a,,14.3.4.a,,15.3.4.a,, | |
| ,15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV ",13.3.4.b,14.3.4.b,15.3.4.b,15.3.4.b,15.3.4.b,,14.3.4.b,,15.3.4.b,, | |
| ,15.3.4.c,No. of H/TG people subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.4.c,14.3.4.c,15.3.4.c,15.3.4.c,15.3.4.c,,14.3.4.c,,15.3.4.c,, | |
| ,15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",13.3.4.d,14.3.4.d,15.3.4.d,15.3.4.d,15.3.4.d,,14.3.4.d,,15.3.4.d,, | |
| ,15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.1.a,14.4.1.a,15.4.1.a,15.4.1.a,15.4.1.a,,14.4.1.a,,15.4.1.a,, | |
| ,15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.1.b,14.4.1.b,15.4.1.b,15.4.1.b,15.4.1.b,,14.4.1.b,,15.4.1.b,, | |
| ,15.4.1.c,"Out of the above, number of males treated for Syphilis ",13.4.1.c,14.4.1.c,15.4.1.c,15.4.1.c,15.4.1.c,,14.4.1.c,,15.4.1.c,, | |
| ,15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.2.a,14.4.2.a,15.4.2.a,15.4.2.a,15.4.2.a,,14.4.2.a,,15.4.2.a,, | |
| ,15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.2.b,14.4.2.b,15.4.2.b,15.4.2.b,15.4.2.b,,14.4.2.b,,15.4.2.b,, | |
| ,15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",13.4.2.c,14.4.2.c,15.4.2.c,15.4.2.c,15.4.2.c,,14.4.2.c,,15.4.2.c,, | |
| ,15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.3.a,14.4.3.a,15.4.3.a,15.4.3.a,15.4.3.a,,14.4.3.a,,15.4.3.a,, | |
| ,15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.3.b,14.4.3.b,15.4.3.b,15.4.3.b,15.4.3.b,,14.4.3.b,,15.4.3.b,, | |
| ,15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",13.4.3.c,14.4.3.c,15.4.3.c,15.4.3.c,15.4.3.c,,14.4.3.c,,15.4.3.c,, | |
| ,15.5.1,Widal tests- Number Tested ,,14.5.1.,15.5.1.,15.5.1.,15.5.1.,,14.5.1.,,15.5.1.,, | |
| ,15.5.2,Widal tests- Number Positive ,,14.5.2.,15.5.2.,15.5.2.,15.5.2.,,14.5.2.,,15.5.2.,, | |
| ,15.6.1.a.i,X-ray(Inhouse) ,,14.6.1.a.i,15.6.1.a.i,15.6.1.a.i,15.6.1.a.i,,14.6.1.a.i,8.2.1.a,15.6.1.a.i,, | |
| ,15.6.1.a.i.1,"X-ray(Inhouse)-No. of chest X-rays done on patients with health risks- Diabetes, HIV, Smoking, Alcoholism, low BMI, geriatric population (>60),history of TB, contacts of TB ",,14.6.1.a.i.1 ,15.6.1.a.i.1 ,15.6.1.a.i.1 ,15.6.1.a.i.1 ,,14.6.1.a.i.1,8.2.1.a.i,15.6.1.a.i.1 ,, | |
| ,15.6.1.a.ii,X-ray(Outsource) ,,14.6.1.a.ii,15.6.1.a.ii,15.6.1.a.ii,15.6.1.a.ii,,14.6.1.a.ii,,15.6.1.a.ii,, | |
| ,15.6.1.b.i,Ultrasonography (USG) (Inhouse) ,,14.6.1.b.i,15.6.1.b.i,15.6.1.b.i,15.6.1.b.i,,14.6.1.b.i,8.2.1.b,15.6.1.b.i,, | |
| ,15.6.1.b.ii,Ultrasonography (USG)(Outsource) ,,14.6.1.b.ii,15.6.1.b.ii,15.6.1.b.ii,15.6.1.b.ii,,14.6.1.b.ii,,15.6.1.b.ii,, | |
| ,15.6.1.c.i,CT scan (Inhouse) ,,,,15.6.1.c.i,15.6.1.c.i,,,8.2.1.c,15.6.1.c.i,, | |
| ,15.6.1.c.ii,CT scan (Outsource) ,,,,15.6.1.c.ii,15.6.1.c.ii,,,,15.6.1.c.ii,, | |
| ,15.6.1.d.i,MRI (Inhouse) ,,,,15.6.1.d.i,15.6.1.d.i,,,8.2.1.d,15.6.1.d.i,, | |
| ,15.6.1.d.ii,MRI (Outsource) ,,,,15.6.1.d.ii,15.6.1.d.ii,,,,15.6.1.d.ii,, | |
| ,15.6.1.e.i,ECG (Inhouse) ,,14.6.1.c.i,15.6.1.c.i,15.6.1.e.i,15.6.1.e.i,,14.6.1.c.i,8.2.1.e,15.6.1.e.i,, | |
| ,15.6.1.e.ii,ECG (Outsource) ,,14.6.1.c.ii,15.6.1.c.ii,15.6.1.e.ii,15.6.1.e.ii,,14.6.1.c.ii,,15.6.1.e.ii,, | |
| M16 [Details of deaths reported],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit ,14.1.1.a,15.1.1.a,16.1.1.a,16.1.1.a,16.1.1.a,,15.1.1.a,9.1.1.,16.1.1.a,, | |
| ,16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit) ,14.1.1.b,15.1.1.b,16.1.1.b,16.1.1.b,16.1.1.b,,15.1.1.b,,16.1.1.b,, | |
| ,16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit ,14.1.2.a,15.1.2.a,16.1.2.a,16.1.2.a,16.1.2.a,,15.1.2.a,9.1.2.,16.1.2.a,, | |
| ,16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit) ,14.1.2.b,15.1.2.b,16.1.2.b,16.1.2.b,16.1.2.b,,15.1.2.b,,16.1.2.b,, | |
| ,16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit ,14.1.3.a,15.1.3.a,16.1.3.a,16.1.3.a,16.1.3.a,,15.1.3.a,9.1.3.,16.1.3.a,, | |
| ,16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit) ,14.1.3.b,15.1.3.b,16.1.3.b,16.1.3.b,16.1.3.b,,15.1.3.b,,16.1.3.b,, | |
| ,16.1.4.a,Infant Deaths (>28 days to below 12 months) at Facility/Facility to facility in transit ,14.1.4.a,15.1.4.a,16.1.4.a,16.1.4.a,16.1.4.a,,15.1.4.a,9.1.4.,16.1.4.a,, | |
| ,16.1.4.b,Infant Deaths (>28 days to below 12 months) At Community (at home or home to facility transit) ,14.1.4.b,15.1.4.b,16.1.4.b,16.1.4.b,16.1.4.b,,15.1.4.b,,16.1.4.b,, | |
| ,16.2.1.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis ,14.2.1.,15.2.1.,16.2.1.,16.2.1.,16.2.1.,,15.2.1.,9.2.1.,16.2.1.,, | |
| ,16.2.2.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia ,14.2.2.,15.2.2.,16.2.2.,16.2.2.,16.2.2.,,15.2.2.,9.2.2.,16.2.2.,, | |
| ,16.2.3.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity ,14.2.3.,15.2.3.,16.2.3.,16.2.3.,16.2.3.,,15.2.3.,9.2.3.,16.2.3.,, | |
| ,16.2.4.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes ,14.2.4.,15.2.4.,16.2.4.,16.2.4.,16.2.4.,,15.2.4.,9.2.4.,16.2.4.,, | |
| ,16.3.1.,Number of Infant Deaths (>28 days - below 12 months) due to Pneumonia ,14.3.1.,15.3.1.,16.3.1.,16.3.1.,16.3.1.,,15.3.1.,9.3.1.,16.3.1.,, | |
| ,16.3.2.,Number of Infant Deaths (>28 days - below 12 months) due to Diarrhoea ,14.3.2.,15.3.2.,16.3.2.,16.3.2.,16.3.2.,,15.3.2.,9.3.2.,16.3.2.,, | |
| ,16.3.3.,Number of Infant Deaths (>28 days - below 12 months) due to Fever related ,14.3.3.,15.3.3.,16.3.3.,16.3.3.,16.3.3.,,15.3.3.,9.3.3.,16.3.3.,, | |
| ,16.3.4.,Number of Infant Deaths (>28 days - below 12 months) due to Measles ,14.3.4.,15.3.4.,16.3.4.,16.3.4.,16.3.4.,,15.3.4.,9.3.4.,16.3.4.,, | |
| ,16.3.5.,Number of Infant Deaths (>28 days - below 12 months) due to Others ,14.3.5.,15.3.5.,16.3.5.,16.3.5.,16.3.5.,,15.3.5.,9.3.5.,16.3.5.,, | |
| ,16.4.1.,Number of Child Deaths (1 - below 5 years) due to Pneumonia ,14.4.1.,15.4.1.,16.4.1.,16.4.1.,16.4.1.,,15.4.1.,9.4.1.,16.4.1.,, | |
| ,16.4.2.,Number of Child Deaths (1 - below 5 years) due to Diarrhoea ,14.4.2.,15.4.2.,16.4.2.,16.4.2.,16.4.2.,,15.4.2.,9.4.2.,16.4.2.,, | |
| ,16.4.3.,Number of Child Deaths (1 - below 5 years) due to Fever related ,14.4.3.,15.4.3.,16.4.3.,16.4.3.,16.4.3.,,15.4.3.,9.4.3.,16.4.3.,, | |
| ,16.4.4.,Number of Child Deaths (1 - below 5 years) due to Measles ,14.4.4.,15.4.4.,16.4.4.,16.4.4.,16.4.4.,,15.4.4.,9.4.4.,16.4.4.,, | |
| ,16.4.5.,Number of Child Deaths (1 - below 5 years) due to Others ,14.4.5.,15.4.5.,16.4.5.,16.4.5.,16.4.5.,,15.4.5.,9.4.5.,16.4.5.,, | |
| ,16.5.1.,Number of Maternal Deaths at facility due to APH (Antepartum Haemmorhage) ,14.5.1.,15.5.1.,16.5.1.,16.5.1.,16.5.1.,,15.5.1.,9.5.1.,16.5.1.,, | |
| ,16.5.2.,Number of Maternal Deaths at facility due to PPH (Post-Partum Haemmorhage) ,14.5.2.,15.5.2.,16.5.2.,16.5.2.,16.5.2.,,15.5.2.,9.5.2.,16.5.2.,, | |
| M16 [Details of deaths reported],16.5.3.,"Number of Maternal Deaths at facility due to Pregnancy related infection and sepsis, Fever ",14.5.3.,15.5.3.,16.5.3.,16.5.3.,16.5.3.,,15.5.3.,9.5.3.,16.5.3.,, | |
| ,16.5.4.,Number of Maternal Deaths at facility due to Abortion and/ or its complication ,14.5.4.,15.5.4.,16.5.4.,16.5.4.,16.5.4.,,15.5.4.,9.5.4.,16.5.4.,, | |
| ,16.5.5.,Number of Maternal Deaths at facility due to Obstructed/prolonged labour ,14.5.5.,15.5.5.,16.5.5.,16.5.5.,16.5.5.,,15.5.5.,9.5.5.,16.5.5.,, | |
| ,16.5.6.,"Number of Maternal Deaths at facility due to Severe hypertension/fits/Pre Eclampsia/Eclampsia in pregnancy, during delivery and puerperium ",14.5.6.,15.5.6.,16.5.6.,16.5.6.,16.5.6.,,15.5.6.,9.5.6.,16.5.6.,, | |
| ,16.5.7.,Number of Maternal Deaths at facility due to Other/Unknown Causes ,14.5.7.,15.5.7.,16.5.7.,16.5.7.,16.5.7.,,15.5.7.,9.5.7.,16.5.7.,, | |
| ,16.5.8.,"Age wise total Maternal Deaths, occurred at Facility ",14.5.8.,15.5.8.,16.5.8.,16.5.8.,16.5.8.,,15.5.8.,9.5.8.,16.5.8.,, | |
| ,16.5.8.a,"Out of total number of maternal deaths at facility, deaths with age less than <15 years ",14.5.8.a,15.5.8.a,16.5.8.a,16.5.8.a,16.5.8.a,,15.5.8.a,9.5.8.a,16.5.8.a,, | |
| ,16.5.8.b,"Out of total number of maternal deaths at facility, deaths with age 15-19 years ",14.5.8.b,15.5.8.b,16.5.8.b,16.5.8.b,16.5.8.b,,15.5.8.b,9.5.8.b,16.5.8.b,, | |
| ,16.5.8.c,"Out of total number maternal deaths at facility, deaths with age more than >19-49 years ",14.5.8.c,15.5.8.c,16.5.8.c,16.5.8.c,16.5.8.c,,15.5.8.c,9.5.8.c,16.5.8.c,, | |
| ,16.5.8.d,"Out of total number maternal deaths at facility, deaths with age more than >49 years ",14.5.8.d,15.5.8.d,16.5.8.d,16.5.8.d,16.5.8.d,,15.5.8.d,9.5.8.d,16.5.8.d,, | |
| ,16.5.9.,"Total Maternal Deaths, occurred at Home to be reported at Block level",,,,,,,,,,3.1.1., | |
| ,16.5.10.,Maternal Death in transit to be reported at Block level,,,,,,,,,,3.1.2., | |
| ,16.5.11.a,"Out of total number of maternal deaths (Home & Transit deaths), deaths with age less than <15 years",,,,,,,,,,3.2.1., | |
| ,16.5.11.b,"Out of total number of maternal deaths (Home & Transit deaths), deaths with age 15-19 years",,,,,,,,,,3.2.2., | |
| ,16.5.11.c,"Out of total number maternal deaths (Home & Transit deaths), deaths with age more than >19-49 years",,,,,,,,,,3.2.3., | |
| ,16.5.11.d,"Out of total number maternal deaths (Home & Transit deaths), deaths with age more than >49 years",,,,,,,,,,3.2.4., | |
| ,16.5.12.a,Number of Maternal Deaths (Home & Transit deaths) due to APH (Antepartum Haemmorhage),,,,,,,,,,3.3.1., | |
| ,16.5.12.b,Number of Maternal Deaths (Home & Transit deaths) due to PPH (Post-Partum Haemmorhage),,,,,,,,,,3.3.2., | |
| ,16.5.12.c,"Number of Maternal Deaths (Home & Transit deaths) due to Pregnancy related infection and sepsis, Fever",,,,,,,,,,3.3.3., | |
| ,16.5.12.d,Number of Maternal Deaths (Home & Transit deaths) due to abortion and/ or its complication,,,,,,,,,,3.3.4., | |
| ,16.5.12.e,Number of Maternal Deaths (Home & Transit deaths) due to Obstructed/prolonged labour,,,,,,,,,,3.3.5., | |
| M16 [Details of deaths reported],16.5.12.f,"Number of Maternal Deaths (Home & Transit deaths) due to Severe hypertension/fits/Pre Eclampsia/Eclampsia & in pregnancy, during delivery and puerperium",,,,,,,,,,3.3.6., | |
| ,16.5.12.g,Number of Maternal Deaths (Home & Transit deaths) due to Other/Unknown Causes,,,,,,,,,,3.3.7., | |
| ,16.6.,Total Facility Based Maternal Death Reviews (FBMDR) done,,,16.6.,16.6.,16.6.,,,9.6.,16.6.,, | |
| ,16.7.1.,Number of deaths due to Diarrhoeal diseases ,14.6.1.,15.6.1.,16.7.1.,16.7.1.,16.7.1.,,15.6.1.,,16.7.1.,, | |
| ,16.7.2.,Number of deaths due to Tuberculosis ,14.6.2.,15.6.2.,16.7.2.,16.7.2.,16.7.2.,,15.6.2.,,16.7.2.,, | |
| ,16.7.3.,Number of deaths due to Respiratory diseases including infections (other than TB) ,14.6.3.,15.6.3.,16.7.3.,16.7.3.,16.7.3.,,15.6.3.,,16.7.3.,, | |
| ,16.7.4.,Number of deaths due to Other Fever Related ,14.6.4.,15.6.4.,16.7.4.,16.7.4.,16.7.4.,,15.6.4.,,16.7.4.,, | |
| ,16.7.5.,Number of deaths due to Heart disease/Hypertension related ,14.6.5.,15.6.5.,16.7.5.,16.7.5.,16.7.5.,,15.6.5.,,16.7.5.,, | |
| ,16.7.6.,Number of deaths due to Cancer ,14.6.6.,15.6.6.,16.7.6.,16.7.6.,16.7.6.,,15.6.6.,,16.7.6.,, | |
| ,16.7.7.,Number of deaths due to Neurological disease including strokes ,14.6.7.,15.6.7.,16.7.7.,16.7.7.,16.7.7.,,15.6.7.,,16.7.7.,, | |
| ,16.7.8.,Number of deaths due to Accidents/Burn cases ,14.6.8.,15.6.8.,16.7.8.,16.7.8.,16.7.8.,,15.6.8.,,16.7.8.,, | |
| ,16.7.9.,Number of deaths due to Animal bites and stings ,14.6.9.,15.6.9.,16.7.9.,16.7.9.,16.7.9.,,15.6.9.,,16.7.9.,, | |
| ,16.7.10.,Number of deaths due to Known Acute Disease ,14.6.10.,15.6.10.,16.7.10.,16.7.10.,16.7.10.,,15.6.10.,,16.7.10.,, | |
| ,16.7.11.,Number of deaths due to Known Chronic Disease ,14.6.11.,15.6.11.,16.7.11.,16.7.11.,16.7.11.,,15.6.11.,,16.7.11.,, | |
| ,16.7.12.,Number of deaths due to Other Causes ,14.6.12.,15.6.12.,16.7.12.,16.7.12.,16.7.12.,,15.6.12.,,16.7.12.,, | |
| ,16.8.1.,Number of Deaths due to Malaria- Plasmodium Vivax ,14.7.1.,15.7.1.,16.8.1.,16.8.1.,16.8.1.,,15.7.1.,,16.8.1.,, | |
| ,16.8.2.,Number of Deaths due to Malaria- Plasmodium Falciparum ,14.7.2.,15.7.2.,16.8.2.,16.8.2.,16.8.2.,,15.7.2.,,16.8.2.,, | |
| ,16.8.3.,Number of Deaths due to Kala Azar ,,15.7.3.,16.8.3.,16.8.3.,16.8.3.,,15.7.3.,,16.8.3.,, | |
| ,16.8.4.,Number of Deaths due to Dengue ,,15.7.4.,16.8.4.,16.8.4.,16.8.4.,,15.7.4.,,16.8.4.,, | |
| ,16.8.5.,Number of Deaths due to Acute Encephelitis Syndrome (AES) ,,15.7.5.,16.8.5.,16.8.5.,16.8.5.,,15.7.5.,,16.8.5.,, | |
| ,16.8.6.,Number of Deaths due to Japanese Encephalitis (JE) ,,15.7.6.,16.8.6.,16.8.6.,16.8.6.,,15.7.6.,,16.8.6.,, | |
| ,16.9.,Total Deaths (5 years and above of age): Excluding in-transit & maternal deaths ,14.8.,15.8.,16.9.,16.9.,16.9.,,15.8.,9.7.,16.9.,, | |
| ,16.9.1.,5 years and above to below 10 years ,14.8.1.,15.8.1.,16.9.1.,16.9.1,16.9.1.,,15.8.1.,9.7.1,16.9.1,, | |
| ,16.9.2.,10 year and above to below 19 years ,14.8.2.,15.8.2.,16.9.2.,16.9.2,16.9.2.,,15.8.2.,9.7.2,16.9.2,, | |
| ,16.9.3.,Adult 19 years and above ,14.8.3.,15.8.3.,16.9.3.,16.9.3,16.9.3.,,15.8.3.,9.7.3,16.9.3,, | |
| ,16.10.1.,In-transit Deaths: 1 year and below 5 years ,14.9.1.,15.9.1.,16.10.1,16.10.1,16.10.1,,15.9.1.,,16.10.1,, | |
| ,16.10.2.,In-transit Deaths: 5 years and above to below 10 years ,14.9.2.,15.9.2.,16.10.2,16.10.2,16.10.2,,15.9.2.,,16.10.2,, | |
| ,16.10.3.,In-transit Deaths: 10 year and above to below 19 years ,14.9.3.,15.9.3.,16.10.3,16.10.3,16.10.3,,15.9.3.,,16.10.3,, | |
| ,16.10.4.,In-transit Deaths: Adult 19 years and above ,14.9.4.,15.9.4.,16.10.4,16.10.4,16.10.4,,15.9.4.,,16.10.4,, | |
| M17 [QA & BEMMP],17.1.1.,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,,16.1.1.,17.1.1.,17.1.1.,17.1.1.,,16.1.1.,,17.1.1.,, | |
| ,17.1.2.,No. of registered Haematology tests reported EQAS Compliant ,,16.1.2.,17.1.2.,17.1.2.,17.1.2.,,16.1.2.,,17.1.2.,, | |
| M17 [QA & BEMMP],17.1.3.,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,,16.1.3.,17.1.3.,17.1.3.,17.1.3.,,16.1.3.,,17.1.3.,, | |
| ,17.1.4.,No. of registered Bio chemistry tests report EQAS Compliant ,,16.1.4.,17.1.4.,17.1.4.,17.1.4.,,16.1.4.,,17.1.4.,, | |
| ,17.1.5.,"Total Quantity of Bio medical waste generated in Kg for the month - (All Yellow, Red, white & Blue) ",15.1.1.,16.1.5.,17.1.5.,17.1.5.,17.1.5.,,16.1.5.,,17.1.5.,, | |
| ,17.1.6.,Total Quantity of General waste generated in Kg for the month ,15.1.2.,16.1.6.,17.1.6.,17.1.6.,17.1.6.,,16.1.6.,,17.1.6.,, | |
| ,17.2.1.,Total number of breakdown calls reported for the month ,,16.2.1.,17.2.1.,17.2.1.,17.2.1.,,16.2.1.,,17.2.1.,, | |
| ,17.2.2.,Total number of breakdown attended for the month ,,16.2.2.,17.2.2.,17.2.2.,17.2.2.,,16.2.2.,,17.2.2.,, | |
| ,17.2.3.,Number of visit made by the service engineer/ BME for the month ,,16.2.3.,17.2.3.,17.2.3.,17.2.3.,,16.2.3.,,17.2.3.,, | |
| M19 [Death Reviews (DR) Done],19.1.,"Total Maternal Deaths Reviewed (MDR) by CMO, out of total reported maternal deaths",,,,,,,,,,,2.1. | |
| ,19.2.,"Total Maternal Deaths Reviewed (MDR) by DM, out of total reported maternal deaths",,,,,,,,,,,2.2. | |
| ,19.3.,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),,,,,,,,,,,2.3. | |
| ,19.4.,Total number of Child Deaths Reviewed by CMHO Level,,,,,,,,,,,2.4. | |
| ,19.5.,Total number of Child Deaths Reviewed by DM Level,,,,,,,,,,,2.5. | |
| M20 [National Ambulance Services ],20.1.,Average response time (call to scene) for all BLS Ambulances in the district during the month,,,,,,,,,,,3.1. | |
| ,20.2.,Average response time (call to scene) for all ALS Ambulances in the district during the month,,,,,,,,,,,3.2. | |
| ,20.3.,Average number of trips per day by all ALS Ambulances in the district during the month,,,,,,,,,,,3.3. | |
| ,20.4.,Average number of trips per day by all BLS Ambulances in the district during the month,,,,,,,,,,,3.4. | |
| ,20.5.,Average kilometres travelled by all ALS Ambulances in the district during the month,,,,,,,,,,,3.5. | |
| ,20.6.,Average kilometres travelled by all BLS Ambulances in the district during the month,,,,,,,,,,,3.6. | |
| M21 [National Leprosy Eradication Programme (NLEP)],21.1.,No. of new leprosy cases found during monthly survey,,,,,,,,,,,4.1. | |
| ,21.2.,No. of Childhood Leprosy cases (1-14) reported in a month,,,,,,,,,,,4.2. | |
| ,21.3.,No. of new Leprosy cases with Grade 2 disability reported in a month,,,,,,,,,,,4.3. | |
| ,21.4.,No. of leprosy patients undergone Reconstructive Surgery in a month,,,,,,,,,,,4.4. | |
| M22 [National Oral Health Programme (NOHP)],21.5.1.,Total number of oral health camps organized at community/village level,,,,,,,,,,,5.1. | |
| ,21.5.1.a.,Number of oral health camps ONLY for screening organized at community/village level,,,,,,,,,,,5.2. | |
| ,21.5.1.b.,Number of oral health camps ONLY for treatment organized at community/village level,,,,,,,,,,,5.3. | |
| M22 [National Oral Health Programme (NOHP)],21.5.2.,Total Number of oral health camps organized at school level for school children,,,,,,,,,,,5.4. | |
| ,21.5.2.a,Number of oral health camps ONLY for screening organized at school level for school children,,,,,,,,,,,5.5. | |
| ,21.5.2.b,Number of oral health camps ONLY for treatment organized at school level for school children,,,,,,,,,,,5.6. | |
| M18 [Stock Position (During the Month)],18.1.,IFA tablets (Red) ,1. Balance From Previous Month,,,,,,,,,,1.1 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |
| ,18.2.,IFA - Blue (Adolescent 10-19 yrs) ,1. Balance From Previous Month,,,,,,,,,,1.2 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |
| ,18.3.,IFA- Pink (Junior 5-9 yrs) ,1. Balance From Previous Month,,,,,,,,,,1.3 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |
| ,18.4.,IFA Syrup (Paediatric) ,1. Balance From Previous Month,,,,,,,,,,1.4 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |
| ,18.5.,RTI /STI colour coded syndromic kits ( I to VII) ,1. Balance From Previous Month,,,,,,,,,,1.5 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |
| ,18.6.,Albendazole 400 mg tablets ,1. Balance From Previous Month,,,,,,,,,,1.6 | |
| ,,,2. Stocks Received,,,,,,,,,, | |
| ,,,3. Unusable Stock,,,,,,,,,, | |
| ,,,4. Stock Distributed,,,,,,,,,, | |
| ,,,5. Total Stock,,,,,,,,,, | |